(Q41936594)

14 October 2017

EMT twists the road to PI3K. (English)

1 reference

14 October 2017

Matthew J Niederst

1

1 reference

PMC publication ID

3918580

14 October 2017

Cyril H Benes

series ordinal

2

1 reference

14 October 2017

1 February 2014

1 reference

14 October 2017

1 reference

14 October 2017

4

1 reference

14 October 2017

2

1 reference

14 October 2017

149-151

1 reference

Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918580

10.1158/2159-8290.CD-13-1030

5 June 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference

PMC publication ID

3918580

14 October 2017

PubMed publication ID

24501304

1 reference

PMC publication ID

3918580